Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 08:01 am Purchase |
2020-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC |
AVORO CAPITAL ADVISORS LLC | 1,670,000 6.500% |
564,001 (+50.99%) |
Filing History |
| 2021-02-12 08:00 am Purchase |
2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
AVORO CAPITAL ADVISORS LLC | 800,000 8.200% |
275,000 (+52.38%) |
Filing History |
| 2021-02-12 08:00 am Purchase |
2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
AVORO CAPITAL ADVISORS LLC | 4,535,000 9.020% |
621,565 (+15.88%) |
Filing History |
| 2020-10-23 5:25 pm Sale |
2020-10-23 | 13D | IMMUNOMEDICS INC IMMU |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-21,000,000 (Position Closed) |
Filing History |
| 2020-09-01 12:25 pm Purchase |
2020-08-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
AVORO CAPITAL ADVISORS LLC | 10,300,000 14.950% |
4,800,000 (+87.27%) |
Filing History |